Psychiatry & Big Pharma: Exposed

How the Psychiatrist?s Bible, the DSM, was Actually Written, and Why Psychiatry is Such Big Business

The Weekend University, Dr James Davies, PhD

Discover how psychiatrist and anthropologist Dr. James Davies reveals the hidden forces shaping modern psychiatric diagnosis and drug treatment, and what this means for truly supporting mental health and human suffering.

Synopsis

In this nearly two‑hour lecture, Dr. James Davies explains how modern psychiatry, guided by the Diagnostic and Statistical Manual of Mental Disorders (DSM) and heavily influenced by pharmaceutical interests, has expanded the number of “disorders” while often lacking solid biological evidence for these diagnoses. He traces how normal human suffering has been increasingly medicalized, how many psychiatric drugs work no better than placebos for many people, and how clinical “consensus” and even voting—rather than rigorous science—helped create and define many categories in the DSM. Through interviews with key DSM architects and archival research, Davies exposes the political, economic, and cultural forces behind psychiatric labeling, raising critical questions about overprescribing, long‑term drug harm, and whether current systems truly serve patients’ wellbeing. He also invites viewers to reconsider how power, profit, and professional status can shape what counts as “mental illness,” and to seek more informed, humane, and evidence‑based approaches to emotional distress.

Summary

Psychiatry has dramatically expanded the number of mental disorders in the DSM, from about 100 in the 1960s to around 370 today, often without clear biological markers, effectively medicalizing normal human experiences such as grief, worry, and trauma.
Dr. James Davies’ interviews with DSM‑III architect Dr. Robert Spitzer and other task‑force members reveal that many diagnoses were created and defined through committee consensus and even simple votes, rather than robust scientific data or validated biomarkers.
The DSM‑III introduced a checklist‑based system and roughly 80 new disorders, while DSM‑IV later added dozens more (including via appendices and subdivisions), contributing to a perceived “epidemic” of mental illness and making it easier than ever to receive a psychiatric label.
Davies shows that for most DSM diagnoses, there is little to no solid evidence of specific biological causes; psychiatry often names a disorder first and only later (if ever) seeks underlying pathology, the reverse of usual medical practice.
The close relationship between psychiatry and Big Pharma has biased the field toward pharmacological solutions, with issues such as buried negative trials, overstated drug efficacy, minimized side effects, and financial incentives for clinicians to promote particular drugs.
Case examples—like the controversial “self‑defeating personality disorder”—illustrate how weak research, small samples, and political considerations (including gender and power issues) can shape which labels are added or retained.
Davies argues that this system can create stigma, confuse people about the true nature and causes of their distress, and in many cases lead to long‑term overprescribing that may do more harm than good, especially when used beyond short‑term crisis support.
Ultimately, the lecture urges viewers to question the authority of psychiatric categories, recognize the role of power and industry influence, and advocate for more transparent, evidence‑based, and humane responses to mental health challenges.

Video Description

Get early access to our latest psychology lectures: http://bit.ly/new-talks5
You can follow James Davies on Twitter here: @JDaviesPhD (https://bit.ly/JD-twitter)

Why, without solid scientific justification, has the number of mental disorders risen from 106 in the 1960s, to around 370 today?

Why has the definition of mental disorder expanded to include ever more domains of human experience?

In the first part of this lecture, Dr James Davies will take us behind the scenes of how the psychiatrist’s bible, the DSM, was actually written – did science drive the construction of new mental disorder categories like ADHD and major depression or were less scientific and more unexpected processes at play? His exclusive interviews with the creators of the DSM reveal the answer.

The second part will address why psychiatry is such big business, and why, on the whole, it may be doing more harm than good. You’ll get insider knowledge on how psychiatry has put riches and medical status above patients’ well-being. The charge sheet is damning; negative drug trials routinely buried; antidepressants that work no better than placebos; research regularly manipulated to produce positive results; doctors, seduced by huge pharmaceutical rewards, creating more disorders and prescribing more pills; and ethical, scientific and treatment flaws unscrupulously concealed by mass-marketing.

You’ll learn the true human cost of an industry that, in the name of helping others, has actually been helping itself.

Dr James Davies graduated from the University of Oxford in 2006 with a DPhil in Social and Medical Anthropology.

He is a Reader in Social Anthropology and Mental Health at the University of Roehampton and a practicing psychotherapist. James has delivered lectures at universities such as Harvard, Yale, Oxford, Oslo, Brown, UCL and Columbia.

He has written for The Times, The New Scientist, The Guardian and Salon, and is author of the bestselling book: Cracked: why psychiatry is doing more harm than good.

James is the co-founder of the Council for Evidence-based Psychiatry, now secretariat to the All-Party Parliamentary Group for Prescribed Drug Dependence. His latest book: ‘Mental Health in Crisis’ will be published later this year.

Links:

Get our latest psychology lectures emailed to your inbox: http://bit.ly/new-talks5

Check out our next event: http://theweekenduniversity.com/events/

Dr Davies’ book: https://amzn.to/33OAMuc

Transcript Summary

Who Dr. James Davies Is

Davies opens by introducing himself as a medical and social anthropologist and practicing psychotherapist who has worked in NHS outpatient psychotherapy settings and for the charity Mind. In those roles he became increasingly concerned that psychiatric diagnoses often created an illusion of understanding among clinicians, generated stigma for patients, and left many people more confused about the real nature and sources of their distress. He also observed large amounts of what he felt was unnecessary and overly long‑term prescribing of psychiatric medications, which in his view sometimes did more harm than good, especially beyond short‑term use in severe crises.

Why He Wrote “Cracked”

In response to these concerns, Davies immersed himself in critical psychiatry literature for several years and ultimately decided to write a book not for academics, but for the general public receiving psychiatric drugs and diagnoses. He felt that many patients were undertaking powerful interventions without adequate information to make truly informed choices, so his book “Cracked: Why Psychiatry is Doing More Harm Than Good” set out to provide that missing context. The central thesis he advances is countercultural: that over the last 30 years, under a dominant biomedical model, psychiatry has in important ways become bad for our mental health.

Three Core Problems in Modern Psychiatry

Davies identifies three major problems: first, that psychiatric drugs often do not perform as claimed and can be more ineffectual and dangerous than the public is led to believe; second, that psychiatry’s ties to the pharmaceutical industry have become “too cozy,” biasing practice toward drug‑centered interventions; and third, that psychiatry has wrongly medicalized more and more people by reframing painful but normal human experiences as psychiatric disorders. He notes that statistics suggesting one in four people have a mental disorder each year may reflect this reclassification of “painful normality” into “psychiatric abnormality,” rather than a true epidemic of mental disease. He emphasizes that the suffering is real and deserves care, but he challenges the assumption that it is inherently psychiatric in nature.

The DSM as the Engine of Medicalization

Davies argues that the heart of this “illusion of epidemic” lies in the DSM, psychiatry’s diagnostic manual, which lists all mental disorders recognized by the profession. He highlights that the DSM has expanded faster than almost any other medical manual: from around 100 disorders in the early 1960s to about 370 today, raising the question of how and why so many new “conditions” appeared. When he investigated, he found very little documentary evidence about how DSM committees actually worked, so he turned to interviews with key figures and archival research at the American Psychiatric Association.

Inside DSM‑III: Interviews with Robert Spitzer

Davies recounts contacting Dr. Robert Spitzer, the influential chair of the DSM‑III task force, and eventually interviewing him at his Princeton home. When Davies asked why DSM‑III introduced approximately 80 new mental disorders, Spitzer explained that these categories were mainly diagnoses clinicians already used in practice but that lacked official recognition; by including them in the DSM, the committee formalized them. Crucially, Spitzer admitted that only a handful of DSM disorders have known biological causes (the “organic disorders”), and that no biological markers had been identified for the vast majority of diagnoses.

Naming Disorders Before Biology

Davies contrasts psychiatry with the rest of mainstream medicine, where diseases are typically named only after some pathological root has been discovered in tissues, cells, or organs; psychiatry, by contrast, tends to name disorders first and seek biological evidence later, if at all. Spitzer acknowledged that new mental disorders could enter the DSM—and thus culture—without any biological evidence, and that inclusion was largely based on behavioral and psychological descriptions plus clinical consensus.

Consensus, Voting, and the Limits of Evidence

When Davies pressed Spitzer on what evidence guided inclusion, Spitzer said the committee primarily relied on whether enough clinicians felt a diagnostic concept was important in their work, turning consensus into the key criterion. Davies points out that agreement does not amount to scientific proof, comparing DSM committee consensus to theologians agreeing about God’s existence. To test whether this was an isolated case, he interviewed other task‑force members such as Dr. Theodore Millon and Dr. Donald Klein, who confirmed that there was very little systematic, solid research backing many DSM‑III disorders and that the team often relied on clinical consensus and even simple votes after sometimes heated three‑hour discussions.

A Case Study: Self‑Defeating Personality Disorder

Davies brings in psychologist Paula J. Kaplan, who had served as a DSM‑III consultant and fought against the proposed “Self‑Defeating Personality Disorder” (SDPD). Kaplan argued that SDPD’s criteria overlapped with behaviors seen in women who were victims of violence, risking pathologizing female survivors and absolving perpetrators. Internal minutes from the DSM archives show the task force acknowledging that Kaplan’s feminist concerns were “political hot potatoes” yet proceeding anyway, despite noting there was “no empirical basis” for the category.

Weak Research Behind a New Diagnosis

Kaplan reviewed the research used to justify SDPD and found it shockingly thin: only two studies. The first involved psychiatrists at a single university, all of whom already believed in SDPD and then applied that label to old case files—a design that proves only shared labeling, not the disorder’s reality. The second was a questionnaire sent to selected members of the American Psychiatric Association; only about 11 percent voted to include SDPD, a tiny and unrepresentative sample. Millon later characterized the broader research base for DSM‑III disorders as “a hodgepodge” that was scattered, inconsistent, and ambiguous, with “modest” amounts of solid science.

Confirmations from Key Insiders

When Davies read Millon’s critique to Spitzer, Spitzer agreed that for many disorders there was not much research, especially not on the exact way they were defined. Spitzer acknowledged that there were “very few disorders” whose definitions resulted directly from specific research data and that validating research on most psychiatric disorders was “very limited indeed.” Donald Klein further confirmed that they had “very little in the way of data” and thus resorted to clinical consensus, which he admitted was “a very poor way to do things,” but in his view better than nothing at the time.

Voting Mental Disorders into Existence

Davies then describes how consensus was operationalized through repeated meetings, memoranda, and ultimately votes, with members literally raising hands to decide whether a symptom counted or whether a disorder should be included. Archival minutes from 12 task‑force meetings show votes taking place in 10 of them, sometimes with dozens of separate votes on definitions, thresholds, and inclusion. Davies stresses that voting is a cultural, not scientific, process; when anything is voted into existence—whether a president or a mental disorder—there is always a substantial risk that it is wrong.

Observations from an Insider Witness

He introduces Rennie Garfinkel, a young psychologist who, as an APA intern, helped with DSM‑III meetings. Garfinkel later recalled that the committees’ behavior looked less like scientific deliberation and more like a group of friends deciding where to eat—different preferences floated until a compromise was reached. She recounted one striking episode where a suggested symptom was rejected because a task‑force member said, “We can’t include that because I do that,” leading the group to treat the behavior as normal simply because someone on the committee engaged in it.

Group Dynamics and Power in the Room

Other participants described the meetings as haphazard, with sudden decisions seemingly based on little more than someone’s impulse or strong personality. The “loudest voices” often prevailed, and some members became quieter as they realized they were in the minority, at which point the group would quickly move to a decision. When outside experts were brought in, meetings could become chaotic, with people talking over each other while Spitzer, busy taking notes, could not chair the sessions in an orderly way.

How DSM‑III Changed Global Psychiatry

Davies cites a New Yorker article and other sources to show that DSM‑III became a runaway success: the nearly 500‑page manual sold out quickly and was adopted not only by psychiatrists but also by psychologists, social workers, nurses, and lawyers. Its categories became the standard for psychiatric research worldwide, shaping studies in countries like Britain, Germany, Australia, Canada, and Scandinavia, and effectively re‑engineering the way mental disorders were conceptualized and investigated. Yet most professionals using the DSM had no idea that many of its categories emerged from limited data, subjective consensus, and small‑group power dynamics, not from firm biological science.

Spitzer’s Own “Revolution” Admission

In one follow‑up phone conversation, Spitzer candidly told Davies that critics were right to say DSM‑III let a small group with a particular viewpoint “take over psychiatry and change it in a fundamental way.” He called it a “revolution” and acknowledged, “We took over because we had the power,” a phrase Davies sees as emblematic of how much psychiatric practice is shaped by who holds institutional and intellectual power. Davies underscores that many key decisions in mental health—definitions, treatments, guidelines—are deeply intertwined with power structures.

DSM‑IV and the Continuing Expansion

The lecture then turns to DSM‑IV, chaired by Dr. Allen Frances and published in 1994, which remained dominant until DSM‑5 in 2013. Frances told Davies that DSM‑IV was intended as a modest, conservative effort that introduced only eight new disorders into the main manual. However, Davies points out that when you include 30 new disorders placed in the appendix and subdivisions of existing diagnoses (which people can still receive in practice), DSM‑IV actually expanded the number of disorders from roughly 270 to about 370—the opposite of true conservatism. Frances later admitted they had learned “tough lessons” about how even minor changes in the manual can be used in ways the authors never intended once they enter the real world.

(The transcript continues beyond the excerpted portion, but the core themes remain: the political and economic construction of diagnostic categories, the role of Big Pharma in driving drug‑centered solutions, and the human cost of overdiagnosis and overmedication.)

Explore these additional related videos…

https://veryhealthybody.com/topics/psychiatry
https://veryhealthybody.com/topics/big-pharma